These results indicate that the direct regulation of the Nrf2 antioxidant response by Brd4 plays an important role in both autophagy and the cytotoxic response of certain AML cells to Brd4 inhibitors, a finding of potential clinical relevance. Here, NFE2L2 is linked to acute myeloid leukemia.